There is no single “best” Medicare plan for every cancer patient, but the choice that protects you most depends on two things: how much financial risk you can absorb and whether you need access to a specific cancer center. For most people facing cancer treatment, Original Medicare paired with a Medigap supplement plan offers the widest provider access and most predictable costs. Medicare Advantage can also work well, but its network restrictions and variable out-of-pocket limits make it a riskier fit for expensive, long-term cancer care.
How Medicare Covers Cancer Treatment
Cancer treatment spans inpatient stays, outpatient visits, and prescription drugs, which means multiple parts of Medicare come into play. Part A covers chemotherapy and surgery when you’re admitted as a hospital inpatient. Part B covers chemotherapy administered in an outpatient setting or a doctor’s office, along with radiation therapy, diagnostic imaging, lab work, and surgeon consultations. If you receive outpatient chemotherapy at a hospital, your copayment is capped at the inpatient deductible amount, which prevents outpatient bills from spiraling above what you’d pay as an admitted patient.
Cancer drugs that are injected or infused by a provider in a clinical setting fall under Part B. Many newer cancer therapies, however, are oral medications you take at home. Some oral anti-cancer drugs are also covered under Part B when they’re the oral equivalent of an IV drug. Anti-nausea medications used within 48 hours of chemotherapy are covered under Part B as well. Any cancer drug that doesn’t meet those criteria falls under Part D, your prescription drug plan. Knowing which “part” covers a given drug matters because the cost-sharing rules differ significantly.
Original Medicare With a Medigap Plan
Under Original Medicare alone, you pay 20% of the Medicare-approved amount for every Part B service after meeting your annual deductible. There is no yearly cap on what you owe. For a cancer patient cycling through months of chemotherapy, scans, radiation, and specialist visits, that 20% coinsurance on six-figure treatment bills can become devastating. This is why most oncology patients on Original Medicare add a Medigap (Medicare Supplement) policy.
Medigap plans are sold by private insurers but follow standardized letter designations. Two plans stand out for cancer patients:
- Plan G covers 100% of your Part B coinsurance and 100% of Part B excess charges (the amount a provider bills above Medicare’s approved rate). After you pay the annual Part B deductible, you owe nothing more for covered services. This is the most comprehensive Medigap option available to new enrollees.
- Plan N also covers Part B coinsurance but requires small copayments for some office visits and emergency room visits. It does not cover Part B excess charges. Monthly premiums are lower than Plan G, but for someone visiting oncologists frequently, those copays add up, and the excess-charge gap introduces unpredictability.
For cancer patients, Plan G is generally the stronger choice. The slightly higher premium buys near-complete predictability: once you’ve paid the Part B deductible, virtually all your Medicare-covered treatment costs are handled. You won’t face surprise bills from providers who charge above the Medicare-approved amount, and you won’t accumulate copays across dozens of appointments.
Why Provider Access Matters
The biggest advantage of Original Medicare with a Medigap plan is that you can see any doctor or hospital in the country that accepts Medicare. For cancer patients, this is not a minor detail. It means you can seek care at National Cancer Institute (NCI)-designated cancer centers like MD Anderson, Memorial Sloan Kettering, or Dana-Farber without worrying about network restrictions.
Medicare Advantage plans, by contrast, use provider networks that may not include top cancer centers. A Kaiser Family Foundation study found that two in five Medicare Advantage plans in areas with an NCI-designated cancer center did not include that center in their network. In some counties, the majority of available Advantage plans excluded the local NCI center entirely. Even when plans did include the affiliated academic medical center, they often didn’t explicitly list the cancer center in their directory, creating confusion about what’s actually covered. NCI cancer centers were especially unlikely to appear in plans with narrow networks.
If you’re dealing with a common early-stage cancer and your local oncologist is in-network, a Medicare Advantage plan may serve you fine. But if your diagnosis is rare, aggressive, or likely to require specialized surgical expertise, the ability to walk into any major cancer center without a referral fight or out-of-network bill is a significant advantage of Original Medicare.
Medicare Advantage: The Trade-Offs
Medicare Advantage plans bundle Part A and Part B (and usually Part D) into a single plan with a built-in annual out-of-pocket maximum. Once you hit that limit, you pay nothing for covered services the rest of the year. That cap, which varies by plan but typically falls between $3,000 and $8,000 for in-network care, is the primary financial appeal for cancer patients. Original Medicare has no such cap on its own.
Many Advantage plans also carry lower monthly premiums than a Medigap policy, and some charge no premium at all beyond the standard Part B premium. They often include extras like dental, vision, and hearing coverage. For healthy enrollees, this looks like a great deal.
The problems emerge during intensive treatment. Network restrictions can limit which oncologists, surgeons, and hospitals you use. Prior authorization requirements may delay access to certain drugs or procedures. Out-of-network care, if the plan covers it at all, comes with a separate (and higher) out-of-pocket maximum. And while the annual cap provides a ceiling, that ceiling resets every January. A cancer patient in active treatment for 18 months could hit the maximum in two consecutive calendar years.
If you’re already enrolled in a Medicare Advantage plan when diagnosed, check your plan’s network carefully. Confirm that your oncologist, the hospital where you’d receive treatment, and any specialists you might need are all in-network. If they aren’t, you may face a difficult decision about switching coverage during the next enrollment period.
Prescription Drug Coverage for Cancer
Starting in 2025, all Medicare Part D plans cap your annual out-of-pocket drug spending at $2,000. Once you reach that threshold, you pay nothing for the rest of the year. This is a major change for cancer patients, many of whom take oral therapies that previously cost thousands per month in the catastrophic coverage phase.
Whether you’re on Original Medicare or Medicare Advantage, you need Part D coverage for any cancer drug that isn’t administered by a provider. Original Medicare enrollees purchase a standalone Part D plan, while Advantage enrollees typically have drug coverage built into their plan. In either case, check your plan’s formulary before starting a new medication. Cancer drugs sit on different formulary tiers, and not every plan covers every drug at the same cost-sharing level. Your oncologist’s office can often help with prior authorizations or appeals if a needed drug isn’t initially covered.
Clinical Trial Coverage
Medicare covers routine patient care costs when you participate in a qualifying clinical trial. This includes office visits, blood tests, imaging, and other standard services you’d receive whether or not you were in the trial. You’ll typically pay 20% coinsurance for Part B services, just as you would for regular treatment. The experimental drug or device itself is usually provided free by the trial sponsor.
This coverage applies under both Original Medicare and Medicare Advantage, though Advantage enrollees should confirm that the trial site and providers are in their plan’s network. Original Medicare’s open provider access again offers more flexibility here, since clinical trials for specific cancers are often concentrated at academic medical centers that may fall outside Advantage networks.
Hospice and Palliative Care
For advanced cancer, Medicare covers hospice care under Part A when two doctors certify a life expectancy of six months or less. Hospice focuses entirely on comfort: pain management, symptom relief, counseling, and support for both patient and family. Once you elect hospice, Medicare stops covering treatments intended to cure your cancer, including curative chemotherapy and related prescriptions. All care for your terminal illness must be arranged through the hospice team.
Palliative care, which focuses on symptom management and quality of life, is different from hospice. You can receive palliative care alongside active cancer treatment at any stage of illness. It’s covered under Part B as a regular medical service. You don’t have to stop fighting the disease to get help managing pain, nausea, or other treatment side effects.
Choosing the Right Path
If you’re newly diagnosed or anticipating expensive cancer treatment, the combination of Original Medicare, a Medigap Plan G, and a standalone Part D plan offers the broadest access and most predictable costs. You can see any Medicare-accepting oncologist, visit any cancer center, and your coinsurance is almost entirely covered after the Part B deductible. The trade-off is a higher monthly premium for the Medigap policy, often $150 to $300 or more depending on your age, location, and the insurer.
Medicare Advantage may be the better fit if you have a solid in-network oncology team, your cancer treatment plan is relatively straightforward, and you prefer a single plan with lower premiums and a built-in spending cap. Just verify network access thoroughly before committing, especially if there’s any chance you’ll need a second opinion or specialized surgery at a major cancer center.
One important timing note: if you’re already past your Medigap open enrollment period (the six months starting when you first enroll in Part B at age 65 or older), insurers can deny you coverage or charge higher premiums based on your health. Switching from Medicare Advantage to Original Medicare with a Medigap plan after a cancer diagnosis may be difficult or expensive. This makes the initial enrollment decision all the more consequential.